{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:02Z","timestamp":1753891982138,"version":"3.41.2"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Yangxue Xifeng Decoction (YXD) has been utilized in clinical settings for the treatment of Tourette Syndrome (TS). However, the action mechanism of YXD needs further research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The ingredients and targets of YXD were identified via database searches and then constructed an active ingredient-target network using Cytoscape. Pathway enrichment analysis was performed via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The core genes were determined by LASSO regression and SVM algorithm. Additionally, we analyzed the immune infiltration. The signaling pathways associated with core genes were investigated through KEGG and GO. We predicted the transcription factors using \u201cRcisTarge\u201d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>127 active ingredients of YXD and 255 targets were obtained. TNF and the IL-17 signaling pathway were the main pathways. <jats:italic>OPRM1<\/jats:italic> and <jats:italic>VIM<\/jats:italic> were screened out as core genes, which were associated with the immune infiltration. The signaling pathways involved in <jats:italic>OPRM1<\/jats:italic> and <jats:italic>VIM<\/jats:italic> were enriched. Furthermore, remarkable correlation was found between <jats:italic>OPRM1<\/jats:italic> and <jats:italic>VIM<\/jats:italic> levels and other TS-related genes such as <jats:italic>MAPT<\/jats:italic> and <jats:italic>MAPT<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:italic>OPRM1<\/jats:italic> and <jats:italic>MAPT,<\/jats:italic> and the signaling pathways are associated with TS. YXD exerts its therapeutic TS through multi-component and multi-targets including immune infiltration.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1397203","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:42:21Z","timestamp":1725943341000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of key biomarkers in tourette syndrome by network pharmacology"],"prefix":"10.3389","volume":"15","author":[{"given":"Jiali","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bbi.2022.07.006","article-title":"Neutrophil-lymphocyte ratios as inflammatory biomarkers in psychiatric patients","volume":"105","author":"Bhikram","year":"2022","journal-title":"Behav Immun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s13311-020-00914-6","article-title":"Current anagement of ics and ourette yndrome: ehavioral, harmacologic, and urgical reatments","volume":"17","author":"Billnitzer","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/s41380-022-01880-5","article-title":"Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoids","author":"Brady","year":"2022","journal-title":"Molecular psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.neubiorev.2013.03.012","article-title":"Neuromodulation in Tourette syndrome: dopamine and beyond","author":"Buse","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1080\/13546805.2020.1760812","article-title":"The cognitive neuropsychiatry of Tourette syndrome","author":"Cavanna","year":"2020","journal-title":"Cogn Neuropsychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.braindev.2020.01.002","article-title":"The association between tic medication therapy and psychiatric comorbidities among patients with Tourette syndrome: national population-based study in Taiwan","author":"Chen","year":"2020","journal-title":"Brain Dev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.heliyon.2023.e12874","article-title":"Emerging therapies and recent advances for Tourette syndrome","volume":"9","author":"Chou","year":"2023","journal-title":"Heliyon"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/mds.27519","article-title":"Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease","volume":"33","author":"Cormier-Dequaire","year":"2018","journal-title":"Electronic"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3389\/fnins.2021.654238","article-title":"Dopaminergic and pioid athways ssociated with mpulse ontrol isorders in Parkinson's isease","volume":"15","author":"Dec. Erga","year":"2018","journal-title":"Front. Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.5334\/tohm.464","article-title":"Association of are enetic ariants in pioid eceptors with ourette yndrome","volume":"9","author":"Depienne","year":"2019","journal-title":"LID"},{"key":"B11","article-title":"Genetic architecture of Tourette syndrome: Our current understanding","author":"Dom\u00e8nech","year":"2021","journal-title":"J. Genet. Psychol."},{"key":"B12","article-title":"Social impact and quality of life in Tourette syndrome","author":"Eapen","year":"","journal-title":"J. Behav. Health"},{"key":"B13","article-title":"Tourette syndrome, co-morbidities, and quality of life","author":"Eapen","year":"","journal-title":"Clin. Psychol. Rev"},{"key":"B14","article-title":"Tics and Tourette syndrome","author":"Efron","year":"2018","journal-title":"Neuropsychiatr. dis. treat"},{"key":"B15","article-title":"Immune dysfunction in Tourette syndrome","author":"Elamin","year":"2013","journal-title":"J. Immunol. Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1523\/JNEUROSCI.0150-11.2011","article-title":"Neurobiology of syndrome: current status and need for further investigation","volume":"31","author":"Felling","year":"2011","journal-title":"J Neurosci"},{"key":"B17","first-page":"1539","article-title":"Diagnostic and statistical manual of mental disorders","volume-title":"linical utility","author":"First","year":"2012"},{"key":"B18","doi-asserted-by":"publisher","first-page":"111198","DOI":"10.1016\/j.biopha.2020.111198","article-title":"An update on the role of miR-124 in the pathogenesis of human disorders","volume":"135","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2022059574","DOI":"10.1542\/peds.2022-059574","article-title":"Innovative therapies for Tourette syndrome: a trial","author":"Gilbert","year":"2024","journal-title":"Pediatrics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/WCO.0000000000000575","article-title":"Tourette syndrome: clinical spectrum, mechanisms and personalized treatments","author":"Hartmann","year":"2018"},{"key":"B21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/ijms22020853","article-title":"Immunological ysfunction in ourette yndrome and elated isorders","volume":"22","author":"Hsu","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/ijms22020853","article-title":"Immunological ysfunction in ourette yndrome and elated isorders","volume":"22","author":"Hsu","year":"","journal-title":"Int J Mol Sci"},{"key":"B24","first-page":"1474","article-title":"Tourette syndrome: clinical features","author":"Johnson","year":"2023"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2022.04.004","article-title":"What makes tics tick? Insights into tourette syndrome","volume-title":"Neuroscience and Biobehavioral Reviews","author":"Kattner","year":"2022"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s40263-018-0559-8","article-title":"Antipsychotic-ssociated symptoms of tourette syndrome","author":"Kim","year":"2018","journal-title":"A Syst Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13059-022-02755-2","article-title":"Positional motif analysis reveals the extent of specificity of protein-RNA interactions observed by CLIP","volume":"23","author":"Kuret","year":"2022","journal-title":"Genome Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopsych.2004.12.004","article-title":"Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome","volume":"57","author":"Leckman","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.biopsych.2014.07.018","article-title":"Transcriptome nalysis of the uman triatum in ourette yndrome","volume":"372","author":"Lennington","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2022.01.008","article-title":"Current understanding of the genetics of Tourette syndrome","volume-title":"Journal of Medical Genetics","author":"Lin","year":"2022"},{"key":"B31","doi-asserted-by":"publisher","first-page":"658323","DOI":"10.3389\/fgene.2021.658323","article-title":"Discovery and alidation of ey iomarkers ased on mmune nfiltrates in Alzheimer's isease","volume":"12","author":"Liu","year":"2021","journal-title":"Front Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3389\/fpsyt.2020.00774","article-title":"Current tatus, iagnosis, and reatment ecommendation for ic isorders in China","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","article-title":"Network harmacology in esearch of Chinese edicine ormula: ethodology, pplication and rospective","volume":"26","author":"Luo","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3389\/fneur.2020.567407","article-title":"What oes mmunology ave to o ith ormal rain evelopment and the athophysiology nderlying ourette yndrome and elated europsychiatric isorders?","volume":"11","author":"Martino","year":"2020","journal-title":"Front. Neurol."},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2014.04.027","article-title":"The role of immune mechanisms in Tourette syndrome","volume-title":"Brain, Behavior, and Immunity","author":"Martino","year":"2015"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-98817-9.00002-8","volume-title":"Tourette syndrome and other tic disorders of childhood","author":"Nilles","year":"2023"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104636","article-title":"Network pharmacology-based analysis of the anti-hyperglycemic active ingredients and experimental validation","volume-title":"Pharmacological Research","author":"Niu","year":"2022"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.5409\/wjcp.v7.i1.36","article-title":"Review of the evidence for the management of co-morbid Tic disorders in children and adolescents with attention deficit hyperactivity disorder","volume":"7","author":"Ogundele","year":"2018","journal-title":"World J Clin Pediatr"},{"key":"B39","first-page":"2162","article-title":"Genetic susceptibility and neurotransmitters in Tourette syndrome","author":"Paschou","year":"2013","journal-title":"Electronic"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1212\/WNL.0000000000007467","article-title":"Comprehensive systematic review summary: reatment of tics in people with Tourette syndrome and chronic tic disorders","volume":"92","author":"Pringsheim","year":"","journal-title":"Neurology"},{"volume-title":"Practice guideline recommendations summary: reatment of tics in people with Tourette syndrome and chronic tic disorders","year":"","author":"Pringsheim","key":"B41"},{"key":"B42","doi-asserted-by":"publisher","first-page":"101998","DOI":"10.1016\/j.nicl.2019.101998","article-title":"Alterations in basal ganglia-cerebello-thalamo-cortical connectivity and whole brain functional network topology in Tourette\u2019s syndrome","volume":"24","author":"Ramkiran","year":"2019","journal-title":"NeuroImage: Clinical"},{"key":"B43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-015-0133-y","article-title":"Circulating miRNAs profiles in Tourette syndrome: molecular data and clinical implications","volume":"8","author":"Rizzo","year":"2015","journal-title":"Mol"},{"volume-title":"A eview of the urrent reatment of ourette yndrome","year":"2020","author":"Seideman Mf Fau - Seideman","key":"B44"},{"key":"B45","article-title":"Traditional Chinese medicine (TCM) therapy","author":"Set","year":"2021","journal-title":"J. Altern. Complement. Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.jep.2022.115876","article-title":"Mechanism of Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation","volume":"302","author":"Shang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B47","first-page":"131","article-title":"Chapter Four - update and recent progress in the neurobiology of Tourette syndrome","volume-title":"International review of movement disorders","author":"Szejko","year":"2022"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/s41380-019-0600-4","article-title":"Variation in the \u03bc-opioid receptor gene (OPRM1) and experiences of felt security in response to a romantic partner's quarrelsome behavior","volume":"26","author":"Tchalova","year":"2021","journal-title":"Mol Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-024-00156-7","article-title":"Synaptic processes and immune-related pathways implicated in Tourette syndrome","volume":"18","author":"Tsetsos","year":"2024","journal-title":"Transl. Psychiatry."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/ijms24021428","article-title":"Molecular andscape of ourette's isorder","volume":"24","author":"Widomska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1155\/2022\/5080282","article-title":"Potential lasma etabolic iomarkers of ourette yndrome iscovery ased on ntegrated ontargeted and argeted etabolomics creening lasma etabolic iomarkers of TS","volume":"2022","author":"Xi","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"B52","first-page":"0065","volume-title":"Traditional Chinese edicine (TCM) therapy","author":"Xiao","year":"2017"},{"key":"B53","unstructured":"Applications of network pharmacology in traditional Chinese medicine research1741427X\n            ZhouZ. A-O.\n            ChenB.\n            ChenS.\n            LinM.\n            ChenY.\n            JinS.\n          10.1155\/2020\/164690520202020"},{"key":"B54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/ijms23010090","article-title":"MiR-155: n mportant egulator of euroinflammation","volume":"23","author":"Zingale","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1397203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:42:31Z","timestamp":1725943351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1397203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":54,"alternative-id":["10.3389\/fphar.2024.1397203"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1397203","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"article-number":"1397203"}}